Showing results (1911-1920 of 2,144) with videos related to
Sort By:
Pageof 215
Nature|July 24, 2024
Neural circuit basis of placebo pain reliefChong Chen, Jesse K Niehaus, Fatih Dinc, et al.International Journal of Cancer|May 15, 2008
Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancerKirsten D Mertz, Francesca Demichelis, Andrea Sboner, et al.Cell|January 12, 2019
Circulating Tumor Cell Clustering Shapes DNA Methylation to Enable Metastasis SeedingSofia Gkountela, Francesc Castro-Giner, Barbara Maria Szczerba, et al.Circulation. Cardiovascular Imaging|December 8, 2016
Characterization of the Changes in Cardiac Structure and Function in Mice Treated With Anthracyclines Using Serial Cardiac Magnetic Resonance ImagingHoshang Farhad, Pedro V Staziaki, Daniel Addison, et al.The Journal of Antimicrobial Chemotherapy|January 22, 2017
Anti-TB drug concentrations and drug-associated toxicities among TB/HIV-coinfected patientsC Sekaggya-Wiltshire, A von Braun, A U Scherrer, et al.The Journal of Biological Chemistry|November 11, 2008
Side chain oxygenated cholesterol regulates cellular cholesterol homeostasis through direct sterol-membrane interactionsSarah E Gale, Emily J Westover, Nicole Dudley, et al.The Journal of Pharmacology and Experimental Therapeutics|August 30, 2011
Farnesyltransferase inhibitor FTI-277 reduces mortality of septic mice along with improved bacterial clearanceWen Yang, Marina Yamada, Yoshiaki Tamura, et al.Journal of Visualized Experiments : Jove|April 22, 2014
Consensus brain-derived protein, extraction protocol for the study of human and murine brain proteome using both 2D-DIGE and mini 2DE immunoblottingFrancisco-Jose Fernandez-Gomez, Fanny Jumeau, Maxime Derisbourg, et al.AIDS (London, England)|July 19, 2014
Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patientsKarin J Metzner, Alexandra U Scherrer, Viktor von Wyl, et al.Circulation|July 20, 2007
Disruption of nitric oxide synthase 3 protects against the cardiac injury, dysfunction, and mortality induced by doxorubicinTomas G Neilan, Sarah L Blake, Fumito Ichinose, et al.Pageof 215